143 related articles for article (PubMed ID: 36933847)
1. A novel mutation (p.Y24N) in NHP2 leads to idiopathic pulmonary fibrosis and lung carcinoma chronic obstructive lung disease by disrupting the expression and nucleocytoplasmic localization of NHP2.
Liu L; Sheng Y; Wang CY; Liu X; Guo T; Peng H; Luo H; Fan LL
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166692. PubMed ID: 36933847
[No Abstract] [Full Text] [Related]
2. NHP2 deficiency impairs rRNA biogenesis and causes pulmonary fibrosis and Høyeraal-Hreidarsson syndrome.
Benyelles M; O'Donohue MF; Kermasson L; Lainey E; Borie R; Lagresle-Peyrou C; Nunes H; Cazelles C; Fourrage C; Ollivier E; Marcais A; Gamez AS; Morice-Picard F; Caillaud D; Pottier N; Ménard C; Ba I; Fernandes A; Crestani B; de Villartay JP; Gleizes PE; Callebaut I; Kannengiesser C; Revy P
Hum Mol Genet; 2020 Apr; 29(6):907-922. PubMed ID: 31985013
[TBL] [Abstract][Full Text] [Related]
3. Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Zhou Y; Murthy JN; Zeng D; Belardinelli L; Blackburn MR
PLoS One; 2010 Feb; 5(2):e9224. PubMed ID: 20169073
[TBL] [Abstract][Full Text] [Related]
4. Hallmarks of the ageing lung.
Meiners S; Eickelberg O; Königshoff M
Eur Respir J; 2015 Mar; 45(3):807-27. PubMed ID: 25657021
[TBL] [Abstract][Full Text] [Related]
5. [Mutation in the telomerase complex component NHP2 in dyskeratosis congenita].
Dereure O
Ann Dermatol Venereol; 2009 Oct; 136(10):752-3. PubMed ID: 19801266
[No Abstract] [Full Text] [Related]
6. The Role of miRNAs in Extracellular Matrix Repair and Chronic Fibrotic Lung Diseases.
Usman K; Hsieh A; Hackett TL
Cells; 2021 Jul; 10(7):. PubMed ID: 34359876
[TBL] [Abstract][Full Text] [Related]
7. NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.
Szema AM; Forsyth E; Ying B; Hamidi SA; Chen JJ; Hwang S; Li JC; Sabatini Dwyer D; Ramiro-Diaz JM; Giermakowska W; Gonzalez Bosc LV
PLoS One; 2017; 12(1):e0170606. PubMed ID: 28125639
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.
Vulliamy T; Beswick R; Kirwan M; Marrone A; Digweed M; Walne A; Dokal I
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8073-8. PubMed ID: 18523010
[TBL] [Abstract][Full Text] [Related]
9. The Lung Likes the Little Fella miR-29.
Liu G; Thannickal VJ
Am J Respir Cell Mol Biol; 2017 Dec; 57(6):637-638. PubMed ID: 29192829
[No Abstract] [Full Text] [Related]
10. Role of MicroRNAs in lung disease.
Angulo M; Lecuona E; Sznajder JI
Arch Bronconeumol; 2012 Sep; 48(9):325-30. PubMed ID: 22607962
[TBL] [Abstract][Full Text] [Related]
11. Exploring the cross-phenotype network region of disease modules reveals concordant and discordant pathways between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Halu A; Liu S; Baek SH; Hobbs BD; Hunninghake GM; Cho MH; Silverman EK; Sharma A
Hum Mol Genet; 2019 Jul; 28(14):2352-2364. PubMed ID: 30997486
[TBL] [Abstract][Full Text] [Related]
12. Increased LGR6 Expression Sustains Long-Term Wnt Activation and Acquisition of Senescence in Epithelial Progenitors in Chronic Lung Diseases.
Cortesi EE; Meeusen B; Vanstapel A; Verleden SE; Vanaudenaerde BM; Wuyts WA; Janssens W; Janssens V; Roskams T; Ventura JJ
Cells; 2021 Dec; 10(12):. PubMed ID: 34943945
[TBL] [Abstract][Full Text] [Related]
13. Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic Approaches.
Akram KM; Patel N; Spiteri MA; Forsyth NR
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26797607
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Åhrman E; Hallgren O; Malmström L; Hedström U; Malmström A; Bjermer L; Zhou XH; Westergren-Thorsson G; Malmström J
J Proteomics; 2018 Oct; 189():23-33. PubMed ID: 29501846
[TBL] [Abstract][Full Text] [Related]
15. Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis.
Pan T; Zhou Q; Miao K; Zhang L; Wu G; Yu J; Xu Y; Xiong W; Li Y; Wang Y
Theranostics; 2021; 11(3):1192-1206. PubMed ID: 33391530
[TBL] [Abstract][Full Text] [Related]
16. Autophagy in lung disease pathogenesis and therapeutics.
Ryter SW; Choi AM
Redox Biol; 2015; 4():215-25. PubMed ID: 25617802
[TBL] [Abstract][Full Text] [Related]
17. Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs.
Trahan C; Martel C; Dragon F
Hum Mol Genet; 2010 Mar; 19(5):825-36. PubMed ID: 20008900
[TBL] [Abstract][Full Text] [Related]
18. Telomerase and telomere length in pulmonary fibrosis.
Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
[TBL] [Abstract][Full Text] [Related]
19. Why Does an Aging Smoker's Lung Develop Idiopathic Pulmonary Fibrosis and Not Chronic Obstructive Pulmonary Disease?
Selman M; Martinez FJ; Pardo A
Am J Respir Crit Care Med; 2019 Feb; 199(3):279-285. PubMed ID: 30211626
[No Abstract] [Full Text] [Related]
20. Long-Term Follow-Up of a Case with Dyskeratosis Congenita Caused by NHP2-V126M/X154R Mutation: Genotype-Phenotype Association.
Erdem M; Tüfekçi Ö; Yılmaz Ş; Alacacıoğlu İ; Ören H
Acta Haematol; 2019; 141(1):28-31. PubMed ID: 30472699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
